Data presented at the World Conference on Lung Cancer shows clinical benefit in a significant percentage of patients with advanced adenocarcinoma of the lung. WEST LAFAYETTE, Ind. - Endocyte Inc., a ...

Endocyte, Inc., a cancer drug discovery and development company, presented data from a Phase 2a clinical trial for EC145, currently in development as a potential treatment for advanced ovarian cancer.